Company Snapshot

Read it, Learn it and Do it for your investment Needs
Home > Market > Equity > Company Snapshot
Company Snapshot
Glaxosmithkline Pharmaceuticals Ltd
Pharmaceuticals - Multinational
BSE Code: 500660 NSE Symbol: GLAXO P/E : 47.79
ISIN Demat: INE159A01016 Div & Yield %: 2.04 EPS : 55.42
Book Value: 115.06 Market Cap (Rs. Cr.): 44,867.19 Face Value : 10

Exchange

Stock Price Details
Last Price (₹) 2,679.10
Change -30.60 (-1.14%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 2,625.25 - 2,681.00
52-Week Range 1,924.30 - 3,515.95
Beta (1 Year) 0.65
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap
Corporate Announcements
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - News Verification
Glaxosmithkline Pharmaceuticals Ltd - Disclosure Under Regulation 30
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Other General Purpose
Glaxosmithkline Pharmaceuticals Ltd - Rumour verification - Regulation 30(11)
Glaxosmithkline Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Copy of Newspaper Publication
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Other General Purpose
Glaxosmithkline Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Corporate Details
Incorporation Year : 1924
Chairman : Renu S Karnad
Ownership Group : MNC Asc-Glaxo
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Multinational
Registered Office :

Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra - 400030,
Phone : 91-022-24959595,
Fax : 91-022-24959494
E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com
URL : http://www.gsk-india.com
Investor Returns
Period Date Price() Returns (%)
1Week 01-Aug-2025 2,933.90 -9.73
1Month 08-Jul-2025 3,259.30 -18.74
3Month 08-May-2025 2,740.95 -3.37
6Month 10-Feb-2025 2,141.55 23.67
1Year 08-Aug-2024 2,871.85 -7.78
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
SBI Midcap Fund 1.91 430.57
Kotak Large & Midcap Fund 1.32 372.69
Nippon India Pharma Fund 3.31 288.82
Nippon India Growth Mid Cap .. 0.46 176.79
Aditya Birla SL ELSS Tax Sav.. 1.09 168.35
Peer Groups : Pharmaceuticals - Multinational
Company Last Price() Change(%) 52Week High() 52Week Low() Market Cap()
Abbott India Ltd 32,824.40 0.18 35,921.55 25,260.20 69,751.85
Pfizer Ltd 4,989.65 -0.82 6,452.85 3,742.90 22,826.52
Astrazeneca Pharma India Ltd 8,765.10 0.42 10,653.05 6,222.35 21,912.75
Sanofi India Ltd 5,205.55 0.39 7,593.60 4,145.90 11,988.38
Sanofi Consumer Healthcare India Ltd 5,191.50 0.48 5,954.00 4,360.30 11,956.35